Autl stock price.

Li Auto Company Info. Li Auto, Inc. is a holding company, which engages in the design, development, manufacture, and sale of electric vehicles. Its product, Li ONE, is a large electric sport ...Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers barOverview Financials News Ideas Technicals Forecast AUTL chart Today 9.56% 5 days 11.66% 1 month −4.90% 6 months 154.18% Year to date 10.08% 1 year 206.58% 5 years …Autolus Therapeutics ( NASDAQ: AUTL) added ~7% pre-market Friday after announcing that Phase 2 data for its CAR T cell therapy obe-cel (AUTO1) will be presented at the 2023 American Society of ...

Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers barThe Autolus Therapeutics plc stock price fell by -2.00% on the last day (Tuesday, 13th Feb 2024) from $6.99 to $6.85. During the last trading day the stock fluctuated 7.79% from a day low at $6.55 to a day high of $7.06. The price has risen in 6 of the last 10 days and is up by 16.89% over the past 2 weeks.Discover historical prices for AUTL stock on Yahoo Finance. View daily, weekly or monthly formats back to when Autolus Therapeutics plc stock was issued.

2,039.00 +4.70(+0.23%) Autolus Therapeutics plc (AUTL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 6.20 -0.46 (-6.91%) At close: 04:00PM …

Share price volatility. Over the last 12 months, Autolus Therapeutics's shares have ranged in value from as little as $1.61 up to $7.45. A popular way to gauge a stock's volatility is its "beta". AUTL.US volatility (beta: 1.91) Avg. volatility (beta: 1.00) Low High. Beta is a measure of a share's volatility in relation to the market.In a report released on November 27, Mara Goldstein from Mizuho Securities maintained a Buy rating on Autolus Therapeutics (AUTL – Research Report), with a price target of $12.00.A list of analyst ratings for Autolus Therapeutics (AUTL) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.Feb 16, 2024 · See the latest Autolus Therapeutics PLC ADR stock price (AUTL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Feb 6, 2024 · My initial coverage of Autolus Therapeutics ( NASDAQ: AUTL ), now a $1 billion market cap clinical-stage biopharmaceutical company, rated it a Strong Buy for numerous positive catalysts for 2023 ...

AUTL Stock Price Chart Interactive Chart > Autolus Therapeutics plc - American Depositary Share (AUTL) Company Bio Autolus Therapeutics is developing a pipeline of advanced programmable T cell treatment candidates for blood and solid tumor cancers.

The Enterprise Value as of February 2024 (TTM) for Autolus Therapeutics plc (AUTL) is 858.80M. According to Autolus Therapeutics plc’s latest financial reports and current stock price.The company's current Enterprise Value is 858.80M.This represents a change of 1.83% compared to the average of 44.49M of the last 4 quarters.Stock Price Statistics The stock price has increased by +248.47% in the last 52 weeks. The beta is 1.91, so AUTL's price volatility has been higher than the market average.Find the latest Autolus Therapeutics Ltd (AUTL) stock forecast, 12-month price target, predictions and analyst recommendations.If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...The average one-year price target for Autolus Therapeutics plc - Depositary Receipt (Common Stock) is $9.364. The forecasts range from a low of $4.848 to a high of $13.65. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.The average one-year price target for Autolus Therapeutics plc - Depositary Receipt (Common Stock) is $9.364. The forecasts range from a low of $4.848 to a high of $13.65. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.Feb 14, 2024 ... MOMENTUM IS BUILDING : AUTL STOCK ANALYSIS | AUTOLUS THERAPEUTICS STOCK ... Price Action Trading like a Pro - I share my best tips after 14 years.

Feb 8, 2024 · Get Autolus Therapeutics PLC (AUTL.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments The average one-year price target for Autolus Therapeutics plc - Depositary Receipt () (NasdaqGS:AUTL) has been revised to 9.86 / share. This is an increase of 5.27% from …When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...Autolus Therapeutics plc (Nasdaq: AUTL) announced data presentations at the American Society of Hematology (ASH) Annual Meeting, showing positive results from the FELIX Phase Ib/II study with obe-cel in relapsed/refractory adult B-ALL, long-term remissions with obe-cel, and initial data from the MCARTY Phase I study in multiple …Autolus Therapeutics (AUTL) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.According to 6 analysts, the average rating for AUTL stock is "Strong Buy." The 12-month stock price forecast is $9.0, which is an increase of 35.14% from the …

AUTLNasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. AUTOLUS THERAPEUTICS PLC (AUTL). 5.96. at close. ‎-0.24 ...

1 Day AUTL -0.59% DJIA -0.26% S&P Mid Cap 400 -0.80% Health Care/Life Sciences -0.01% Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and ...Discover historical prices for AUTL stock on Yahoo Finance. View daily, weekly or monthly formats back to when Autolus Therapeutics plc stock was issued.Feb 16, 2024 · With Autolus Therapeutics stock trading at $6.83 per share, the total value of Autolus Therapeutics stock (market capitalization) is $1.19B. Autolus Therapeutics stock was originally listed at a price of $25.00 in Jun 22, 2018. If you had invested in Autolus Therapeutics stock at $25.00, your return over the last 5 years would have been -72.68% ... TCRT : 0.1782 (-3.73%) AUTL : 5.95 (+3.66%) Why Autolus Therapeutics Stock Is Crashing Today Motley Fool - Fri Dec 9, 2022. Shares of Autolus Therapeutics (NASDAQ: AUTL) were crashing 35.9% as of 10:34 a.m. ET on Friday. The steep decline came after the biopharmaceutical company announced the price of a public stock offering...ATHENS, Greece, Nov. 29, 2022 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today reported net income of $1.1 mill... Get a real-time OceanPal Inc. (OP) stock price quote with breaking news, financials, statistics, charts and more.We would like to show you a description here but the site won’t allow us.Complete Autolus Therapeutics Ltd. ADR stock information by Barron's. View real-time AUTL stock price and news, along with industry-best analysis.Get Autolus Therapeutics PLC (AUTL.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAUTL Stock Price Chart Interactive Chart > Autolus Therapeutics plc - American Depositary Share (AUTL) Company Bio. Autolus Therapeutics is developing a pipeline of advanced programmable T cell treatment candidates for blood and solid tumor cancers. Autolus‘ T cell therapies target the the blood cancer ALL either through CD19 (in Phase …Autolus Therapeutics ( NASDAQ: AUTL) added ~7% pre-market Friday after announcing that Phase 2 data for its CAR T cell therapy obe-cel (AUTO1) will be presented at the 2023 American Society of ...

Autolus Therapeutics plc ADR Stock (AUTL) Price Forecast for 2025 ; March, 2025, $10.58, $8.2106 ; April, 2025, $11.91, $10.49 ; May, 2025, $14.30, $14.74 ; June, ...

View the latest Autolus Therapeutics Ltd. ADR (AUTL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Autolus Therapeutics plc careened $0.36 (-5.89%) to $5.75 on light volume today. It has now fallen for the past four days. The BioPharmCatalyst Index soared up 1.36 (+1.33%) to 103.2 today. Virios Therapeutics was the biggest mover in the other direction among all stocks, dropping $0.33 (-40.3%).According to Autolus Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 173,984,101. At the end of ...Webull offers AUTL Ent Holdg (AUTL) historical stock prices, in-depth market analysis, NASDAQ: AUTL real-time stock quote data, in-depth charts, free AUTL ...In depth view into AUTL (Autolus Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Autolus Therapeutics PLC (AUTL) 6.07 -0.13 ( -2.10% ) USD | NASDAQ | Feb 22, 15:57 February 22, 2024. The stock of Autolus Therapeutics plc ADR (NASDAQ: AUTL) has decreased by -6.91 when compared to last closing price of 6.66. Despite this, the company has experienced a -9.49% fall in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-02-12 that Autolus Therapeutics …Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...The latest price target for Autolus Therapeutics ( NASDAQ: AUTL) was reported by Goldman Sachs on Wednesday, December 13, 2023. The analyst firm set a price target for 4.80 expecting AUTL to fall ...The value each AUTL share was expected to gain vs. the value that each AUTL share actually gained. Autolus Therapeutics ( AUTL ) reported Q3 2023 earnings per share (EPS) of -$0.26 , missing estimates of -$0.25 by 5.59% .

AUTL Stock Price Chart Interactive Chart > Autolus Therapeutics plc - American Depositary Share (AUTL) Company Bio Autolus Therapeutics is developing a pipeline of advanced programmable T cell treatment candidates for blood and solid tumor cancers. BX is funding AUTL. Autolus Therapeutics (NASDAQ: AUTL) stock is surging higher in trading Monday following news of a major investment in the clinical-stage biopharmaceutical company. According to ...Find the latest Advance Auto Parts, Inc. (AAP) stock quote, history, news and other vital information to help you with your stock trading and investing.Goldman Sachs Raises Price Target on Autolus Therapeutics to $4.80 From $3.20, Maintains Neutral Rating. Dec. 13. MT. Deutsche Bank Initiates Coverage on Autolus Therapeutics With Buy Rating, $10 Price Target. Nov. 09. MT. Truist Securities Adjusts Price Target on Autolus Therapeutics to $9 From $6, Maintains Buy Rating. 23-08-17.Instagram:https://instagram. best solar company university placesurviving compton dre suge and michel leremote tasksedit apple id on ipad By Volume. Advancing Declining Unchanged Total 487,596,451 395,543,658 868,779,248 14,360,861. Check out the latest AUTOLUS THERAPEUTICS (AUTL) stock quote and chart. View real-time stock prices ...LONDON, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today ... girlfriend avril lavigne lyricslemon ice cream near me We would like to show you a description here but the site won’t allow us.AUTL | AI Stock Analysis for Autolus Therapeutics plc ADR AUTL Including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and More. Ticker. Company. Your search produced no matches. We currently support US stocks and STOXX Europe 600 stocks. this little light of mine The value each AUTL share was expected to gain vs. the value that each AUTL share actually gained.. Autolus Therapeutics (AUTL) reported Q3 2023 earnings per share (EPS) of-$0.26, missing estimates of -$0.25 by 5.59%.In the same quarter last year, Autolus Therapeutics's earnings per share (EPS) was-$0.47.Autolus Therapeutics is expected to …View the latest Apple Inc. (AAPL) stock price, news, historical charts, analyst ratings and financial information from WSJ.